SightfileU.S. market data from official filings

Companies › KOD

KODIAK SCIENCES (KOD)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001468748 · EDGAR filings · Updated 2026-07-17

KODIAK SCIENCES (KOD) has reported institutional ownership of 93.7%, with 188 institutional managers holding positions valued at $2.21B per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.

Institutional ownership
93.7%
Institutional managers
188
Reported 13F value
$2.21B
Insider activity
6 trans.
$60.0M net buying
Data flags
1 active
from SEC filings

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, KODIAK SCIENCES has 188 institutional holders and institutional ownership of 93.7%.

Insider activity

Insiders reported 6 transactions (2 buys, 1 sells) across 3 reporting insiders, with a net reported value of $60.0M.

Data flags from SEC filings

Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2026-05-07 (recurring since 2025-03-27) — source filing. The authoritative details are those stated in the filing itself.

Related companies

GENMAB A/S (GMAB) · SAREPTA THERAPEUTICS INC (SRPT) · VIRIDIAN THERAPEUTICS INC (VRDN) · ALUMIS INC (ALMS) · KINIKSA PHARMACEUTICALS INTL (KNSA) · NEOGEN CORPORATION (NEOG)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-17.